A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis have?
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis has 300 citations in the OpenAlex counts ScholarIQ stores.
When was A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis published?
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis has 2015 year in the ScholarIQ index.
What is the open-access status of A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis?
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis has bronze oa status in the ScholarIQ index.
What is the DOI of A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis?
The DOI for A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis is on the source record.
What is the PMID of A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis?
The PMID for A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis is on the source record.
What is the OpenAlex record for A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis?
The OpenAlex for A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis is on the source record.